DOI: 10.1016/S1671-2927(09)60125-5 14
PMID: Summary Keywords GLP-1 receptor agonists, gut microbiota dysbiosis, gutimmunemetabolic axis, kidney transplantation, post-transplant diabetes mellitus, SGLT2 inhibitors Citation Long J, Zhao J, Gu X and Huang C (2026) Post-transplant diabetes mellitus after kidney transplantation: pathogenesis, risk factors, and management strategies
Decreases in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), liver fat, and serum alanine aminotransferase have also been reported [103]
David Sinclair: One of the problems right now is gene therapy is so hot in biotech, its hard to get your vectors made because companies that make these, they get three requests for every deal they can do